Intravenous fentanyl for cancer pain: A "fast titration" protocol for the emergency room

Journal of Pain and Symptom Management

Volumn 26, Issue 3, 2003, Pages 876-881

  Soares, Luiz Guilherme L ^a,b   Martins, Maurílio ^a   Uchoa, Rudy ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b NONE   (Brazil)

Author keywords

Emergency room; Intravenous fentanyl; Severe cancer pain; Titration

Indexed keywords

FENTANYL; MORPHINE; NALOXONE;

ADULT; AGED; ANALGESIA; ARTICLE; BRADYCARDIA; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DROWSINESS; DRUG SAFETY; EMERGENCY MEDICINE; EMERGENCY TREATMENT; EMERGENCY WARD; FEMALE; HALLUCINATION; HUMAN; HYPOTENSION; MALE; RIGIDITY; SIDE EFFECT; THORAX; TIME; TITRIMETRY; VOMITING;

EID: 0041826884     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(03)00314-2     Document Type: Article

References (28)

1. World Health Organization. National Cancer Control Programmes: Priorities and Managerial Guidelines. 1995;WHO, Geneva.
2. Hagen N.A., Elwood T., Ernst S. Cancer pain emergencies: A protocol for management. J Pain Symptom Manage. 14:1997;45-50.
3. Davis M., Walsh D. Cancer pain syndromes. Eur J Palliat Care. 7:(6):2000;206-209.
4. Mercadante S., Portenoy R. Opioid poorly responsive cancer pain Part 2: Basic mechanisms that could shift dose response for analgesia . J Pain Symptom Manage. 21:2001;255-264.
5. Portenoy R., Hagen N.A. Breakthrough pain: definition and management. Oncology. 3:(Suppl):1989;25-29.
6. Coda B. Opioids. Barash P.G., Cullen B.F., Stoelting R.K. Clinical anesthesia. 1996;329-358 Lippincott-Raven, Philadelphia.
7. Enting R.H., Oldenmenger W.H., Rijt C., et al. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Cancer. 94:2002;3049-3056.
8. Kumar K.S., Rajagopal M.R., Naseema A.M. Intravenous morphine for emergency treatment of cancer pain. Palliat Med. 14:2000;183-188.
9. Radbruch L., Loick G., Schulzek S. Intravenous titration with morphine for emergency treatment of cancer pain. Clin J Pain. 15:1999;173-178.
10. Hill H.F., Saeger L., Bjurstrom R., et al. Steadystate infusions of opioids in human volunteers I. Pharmacokinetic tailoring . Pain. 43:1990;57-67.
11. Mercadante S., Villari P., Ferrera P., et al. Rapid titration with intravenous morphines for severe cancer pain and immediate oral conversion. Cancer. 95:2002;203-208.
12. Herz A., Teschenmacher H.J. Activities and sites of antinociceptive action of morphine-like analgesics and kinetics of distribution following intravenous, intracerebral and intraventricular application. Adv Drug Res. 6:1971;79-119.
13. Balestrieri F., Fisher S. Analgesics. Chernow B. The pharmacological approach to the critically ill patient. 1994;640-650 Williams & Wilkins, Baltimore.
14. Breitbart W., Chandler S., Eagel B., et al. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain. Oncology. 14:(5):2000;695-705.
15. Payne R., Coluzzi P., Hart L., et al. Long-term safety of oral transmucosal fentanyl citrate for breakthrough cancer pain. J Pain Symptom Manage. 22:2001;575-583.
16. Mercadante S., Caligara M., Sapio M., et al. Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure. J Pain Symptom Manage. 13:1997;241-244.
17. Watanabe S., Pereira J., Hanson J., et al. Fentanyl continous subcutaneous infusion for the management of cancer pain: A retrospective study. J Pain Symptom Manage. 16:1998;323-326.
18. Cherny N.J., Chang V., Frager G., et al. Opioid pharmacotherapy in the management of cancer pain. Cancer. 76:(6):1995;1283-1293.
19. Portenoy R.K., Moulin D.E., Rogers A., et al. I.V infusion of opioids for cancer pain: clinical review and guidelines for use. Cancer Treat Rep. 70:1986;575-581.
20. Moryl N., Palma J.S., Kornick C., et al. Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain. 96:2002;325-328.
21. Lawlor P.G., Turner K.S., Hanson J., et al. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Cancer. 82:1998;1167-1173.
22. Ripamonti C., Groff L., Brunelli C., et al. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol. 16:1998;3216-3221.
23. Ripamonti C., De Conno F., Groff L., et al. Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences. Ann Oncol. 9:(1):1998;79-83.
24. Streisand J.B., Bailey P.L., Ashburn M.A., et al. Fentanyl-induced rigidity and unconsciousness in human volunteers. Incidence, duration, and plasma concentrations. Anesthesiology. 78:(4):1993;629-634.
25. Colleau S. The significance of breakthrough pain in cancer. WHO, Cancer Pain Release. 12:(4):1999;1-8.
26. Zech D., Grond S., Lynch J. Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients. Pain. 50:1992;293-301.
27. Schears R.M. Emergency physician's role in end-of-life care. Emerg Med Clin North Am. 17:(2):1999;539-559.
28. Gonzales G.R., Elliot K.J., Portenoy R.K., et al. The impact of a comprehensive evaluation in the management of cancer pain. Pain. 47:1991;141-144.